Products Perampanel Oral Suspension + Perampanel Tablet
Perampanel Oral Suspension + Perampanel Tablet Phase 2 Recruiting 0 watching 0 views this week⚡ Active Pediatric Epileptic Syndrome
Pediatric Epileptic Syndrome, Partial-onset Seizures
May 31, 2019 → Dec 23, 2027
About Perampanel Oral Suspension + Perampanel Tablet Perampanel Oral Suspension + Perampanel Tablet is a phase 2 stage product being developed by Eisai for Pediatric Epileptic Syndrome. The current trial status is recruiting. This product is registered under clinical trial identifier NCT04015141. Target conditions include Pediatric Epileptic Syndrome, Partial-onset Seizures.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT04015141 Phase 2 Recruiting May 31, 2019 Dec 23, 2027 Pediatric Epileptic Syndrome
Product Company Stage Hype Score Ramucirumab Eli Lilly Phase 1 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine Sun Pharmaceutical Phase 1 Eribulin Mesylate Eisai Phase 1 Decitabine + Decitabine Eisai Phase 2 Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily Sumitomo Pharma Phase 1 Remimazolam Tosilate for injection + Propofol Injection Jiangsu Hengrui Medicine Phase 2/3 Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or Linezolid AstraZeneca Phase 2/3 candsartan cilexetil AstraZeneca Phase 3 Durvalumab / Tremelimumab Combination Therapy AstraZeneca Phase 1/2 Rotavirus Vaccine Merck Pre-clinical basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids Novartis Phase 3 VAL489 + VAL489 matching placebo Novartis Phase 3 LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696 Novartis Phase 2/3 Everolimus Novartis Phase 2 Corticosteroids + Cyclosporine + mycophenolate mofetil Roche Phase 2 Entecavir + Lamivudine + Pegylated Interferon Alfa-2A Roche Phase 3 Blinatumomab for Injection Amgen Phase 1 Etanercept Amgen Phase 3 Denosumab Amgen Phase 3
Other Products from Eisai